Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Vital Signs Monitoring

Research Leaders

6 sponsors active, led by Qilu Hospital of Shandong University

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown2
Active Not Recruiting1
Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Vital Signs Monitoring1
  • Neobeat With A Visible Display1
  • Highaltitude Environment1

Active Sponsors

  • Qilu Hospital of Shandong University2
  • Laerdal Medical1
  • Duzce University1
  • Queen's University1
  • Helse Stavanger HF1

Top Investigators

Related Conditions

  • Adverse Cardiac Event1
  • Anesthesia1
  • Vagal Bradycardia1
  • Tonsillitis Hypertrophic1
  • Respiratory Complication1

Activity Timeline